Stimulation of endothelial progenitor cells: a new putative effect of several cardiovascular drugs
- PMID: 20012029
- DOI: 10.1007/s00228-009-0764-y
Stimulation of endothelial progenitor cells: a new putative effect of several cardiovascular drugs
Abstract
The role of vascular endothelium in cardiovascular disorders is well recognized. Mature endothelial cells contribute to the repair of endothelial injury, but they only have a limited capacity to do so. This has led to growing interest and further investigation into circulating endothelial progenitor cells (EPCs) and their role in vascular healing, repair, and postnatal neovascularization. The current perception of vascular health is that of a balance between ongoing injury and resultant vascular repair, mediated at least in part by circulating EPCs. Circulating EPCs play an important role in accelerating endothelialization at areas of vascular damage, and EPC enumeration is a viable strategy for assessing reparative capacity. Recent studies have shown that EPCs are affected both in number and function by several cardiovascular risk factors as well as various cardiovascular disease states, such as hypertension, hypercholesterolemia, and coronary artery disease. The present review summarizes the most relevant studies on the effects of cardiovascular drugs on vascular function and EPCs, focusing on their mechanisms of action.
Similar articles
-
Endothelial progenitor cells in cardiovascular disorders.J Am Coll Cardiol. 2007 Feb 20;49(7):741-52. doi: 10.1016/j.jacc.2006.09.050. J Am Coll Cardiol. 2007. PMID: 17306702 Review.
-
Endothelial progenitor cells: markers of vascular reparative capacity.Ther Adv Cardiovasc Dis. 2008 Jun;2(3):199-213. doi: 10.1177/1753944708093412. Ther Adv Cardiovasc Dis. 2008. PMID: 19124422 Review.
-
Hypoxia inducible factor-1 alpha, endothelial progenitor cells, monocytes, cardiovascular risk, wound healing, cobalt and hydralazine: a unifying hypothesis.Curr Drug Targets. 2008 May;9(5):422-35. doi: 10.2174/138945008784221215. Curr Drug Targets. 2008. PMID: 18473772 Review.
-
Circulating endothelial progenitor cells in cardiovascular disorders.Expert Rev Cardiovasc Ther. 2008 Sep;6(8):1115-21. doi: 10.1586/14779072.6.8.1115. Expert Rev Cardiovasc Ther. 2008. PMID: 18793114 Review.
-
Endothelial progenitor cells: therapeutic target for cardiovascular diseases.J Pharmacol Sci. 2008 Sep;108(1):1-6. doi: 10.1254/jphs.08r01cp. Epub 2008 Sep 6. J Pharmacol Sci. 2008. PMID: 18776710 Review.
Cited by
-
Association of genetic variants in lncRNA GAS5/miR-21/mTOR axis with risk and prognosis of coronary artery disease among a Chinese population.J Clin Lab Anal. 2020 Oct;34(10):e23430. doi: 10.1002/jcla.23430. Epub 2020 Jun 17. J Clin Lab Anal. 2020. PMID: 32557866 Free PMC article.
-
Role of PDGFR-β/PI3K/AKT signaling pathway in PDGF-BB induced myocardial fibrosis in rats.Am J Transl Res. 2014 Nov 22;6(6):714-23. eCollection 2014. Am J Transl Res. 2014. PMID: 25628782 Free PMC article.
-
Levels of circulating CXCR4-positive cells are decreased and negatively correlated with risk factors in cardiac transplant recipients.Heart Vessels. 2011 May;26(3):258-66. doi: 10.1007/s00380-010-0053-9. Epub 2010 Oct 30. Heart Vessels. 2011. PMID: 21052687
-
Sulodexide reduces senescence-related changes in human endothelial cells.Med Sci Monit. 2011 Apr;17(4):CR222-6. doi: 10.12659/msm.881719. Med Sci Monit. 2011. PMID: 21455109 Free PMC article.
-
Reduced levels of circulating endothelial progenitor cells in acute myocardial infarction patients with diabetes or pre-diabetes: accompanying the glycemic continuum.Cardiovasc Diabetol. 2014 Jun 16;13:101. doi: 10.1186/1475-2840-13-101. Cardiovasc Diabetol. 2014. PMID: 24934236 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical